Dashboard
Manage Tickers

XERSXeris Biopharma Holdings, Inc.

Nasdaq xerispharma.com


$ 2.84 $ -0.01 (-0.35 %)    

Thursday, 12-Sep-2024 09:33:05 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 468.45 $ -0.18 (-0.04 %)
DIA $ 410.35 $ 0.89 (0.22 %)
SPY $ 554.74 $ -0.25 (-0.05 %)
TLT $ 100.27 $ -0.10 (-0.1 %)
GLD $ 234.60 $ -0.04 (-0.02 %)
$ 2.86
$ 2.85
$ 2.84 x 200
-- x --
$ 2.85 - $ 2.86
$ 1.46 - $ 3.26
3,687,712
na
426.14M
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-06-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-08-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-11-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-xeris-biopharma-holdings-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Xeri...
08/15/2024 10:14:08

HC Wainwright & Co. analyst Oren Livnat reiterates Xeris Biopharma Holdings (NASDAQ:XERS) with a Buy and maintains $6 pr...

more-than-20m-bet-on-precigen-check-out-these-3-stocks-under-5-insiders-are-aggressively-buying
More Than $20M Bet On Precigen? Check Out ...
08/14/2024 12:57:03

xeris-biopharma-and-2-other-penny-stocks-insiders-are-buying
Xeris Biopharma And 2 Other Penny Stocks I...
08/13/2024 12:53:57

xeris-biopharma-revised-fy24-total-revenue-outlook-to-190m-200m-from-175m-200m-vs-187349m-estimate
Xeris Biopharma Revised FY24 Total Revenue...
08/08/2024 11:04:55

xeris-biopharma-holdings-q2-2024-gaap-eps-010-beats-011-estimate-sales-46512m-beat-45811m-estimate
Xeris Biopharma Holdings Q2 2024 GAAP EPS ...
08/08/2024 11:02:28

Xeris Biopharma Holdings (NASDAQ:XERS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate...

xeris-biopharma-reports-preliminary-q2-total-revenue-to-exceed-47m-representing-over-23-growth-over-last-year-estimate-44894m
Xeris Biopharma Reports Preliminary Q2 Tot...
07/08/2024 11:09:56

xeris-biopharma-names-john-shannon-to-succeed-paul-edick-as-new-ceo-and-board-director
Xeris Biopharma Names John Shannon To Succ...
07/08/2024 11:08:20

The company announced a CEO succession plan effective August 1, 2024, under which Paul R. Edick will be retiring from his day-t...

hc-wainwright--co-reiterates-buy-on-xeris-biopharma-holdings-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Xeri...
05/31/2024 10:29:05

HC Wainwright & Co. analyst Oren Livnat reiterates Xeris Biopharma Holdings (NASDAQ:XERS) with a Buy and maintains $6 pr...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/30/2024 16:31:20

xeris-reports-topline-results-from-its-recently-completed-phase-2-open-label-study-of-xp-8121-for-treatment-of-adults-with-hypothyroidism
Xeris Reports Topline Results From Its Rec...
05/30/2024 11:41:02

Participants who completed the study rated higher treatment satisfaction with XP-8121 compared to oral and a majority (72%) ind...

socket-mobile-and-3-other-stocks-under-3-insiders-are-buying
Socket Mobile And 3 Other Stocks Under $3 ...
05/13/2024 12:51:16

piper-sandler-reiterates-overweight-on-xeris-biopharma-holdings-lowers-price-target-to-3
Piper Sandler Reiterates Overweight on Xer...
05/10/2024 13:39:41

Piper Sandler analyst David Amsellem reiterates Xeris Biopharma Holdings (NASDAQ:XERS) with a Overweight and lowers the pric...

xeris-biopharma-raises-fy24-total-revenue-outlook-to-175m-200m-vs-18443m-estimate-prior-view-170m-200m
Xeris Biopharma Raises FY24 Total Revenue ...
05/09/2024 11:09:50

xeris-biopharma-holdings-q1-eps-014-misses-012-estimate-sales-4064m-miss-4181m-estimate
Xeris Biopharma Holdings Q1 EPS $(0.14) Mi...
05/09/2024 11:05:54

Xeris Biopharma Holdings (NASDAQ:XERS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estima...

why-are-xeris-biopharma-shares-moving-monday
Why Are Xeris Biopharma Shares Moving Monday?
05/06/2024 15:37:53

Xeris Biopharma shares are up Monday after the company announced an exclusive worldwide collaboration and license agreement wit...

xeris-biopharma-enters-into-an-exclusive-worldwide-collaboration-and-license-agreement-with-beta-bionics-financial-terms-undisclosed
Xeris Biopharma Enters Into an Exclusive W...
05/06/2024 11:01:19

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patient lives ...

oppenheimer-initiates-coverage-on-xeris-biopharma-holdings-with-outperform-rating-announces-price-target-of-5
Oppenheimer Initiates Coverage On Xeris Bi...
03/28/2024 10:51:31

Oppenheimer analyst Leland Gershell initiates coverage on Xeris Biopharma Holdings (NASDAQ:XERS) with a Outperform rating an...

hc-wainwright--co-maintains-buy-on-xeris-biopharma-holdings-raises-price-target-to-6
HC Wainwright & Co. Maintains Buy on Xeris...
03/07/2024 11:13:24

HC Wainwright & Co. analyst Oren Livnat maintains Xeris Biopharma Holdings (NASDAQ:XERS) with a Buy and raises the price...

xeris-biopharma-expects-2024-revenue-of-170m-200m-versus-consensus-of-18411m-year-end-cash-cash-equivalents-and-short-term-investments-of-55m-75m
Xeris Biopharma Expects 2024 Revenue Of $1...
03/06/2024 12:08:05

xeris-biopharma-holdings-q4-gaap-eps-010-inline-sales-4439m-beat-4355m-estimate
Xeris Biopharma Holdings Q4 GAAP EPS $(0.1...
03/06/2024 12:04:05

Xeris Biopharma Holdings (NASDAQ:XERS) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate....

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION